Tranexamic acid for heavy bleeding on blood thinners
Treatments studied
Part of Blood & lymphatic, Heart & circulation, Women’s health & pregnancy clinical trials.
This study tests if a medicine called tranexamic acid can safely reduce heavy bleeding during periods for people who are taking blood thinners for a recent blood clot. It is a pilot study to see if a larger trial is possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult who has not gone through menopause and gets regular periods (every 24 to 38 days).
- You were recently diagnosed with a blood clot (like deep vein thrombosis or pulmonary embolism) confirmed by an imaging test.
- You started taking a blood thinner (anticoagulant) within the last 2 weeks.
- You plan to take the blood thinner for at least 3 months.
- You do not have any allergies to the study drug (tranexamic acid), kidney problems, or active bleeding other than your period.
- You are not pregnant or breastfeeding and do not use hormonal birth control (like the pill or IUD).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tranexamic acid, a medicine that helps reduce bleeding, can improve anaemia (low blood iron) in women with heavy periods. If you have anaemia and heavy menstrual bleeding, this treatment might help raise your iron levels.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
This trial is testing if a medicine called tranexamic acid (TXA) can help reduce bleeding during a second-trimester abortion or miscarriage procedure. The goal is to make the procedure safer for patients.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.